Ultragenyx Pharmaceutical (UP0) Q2 2024 Earnings Report
CH:UP0 Q2 2024 EPS Results
- Actual EPS
- -CHF 1.25
- Consensus EPS
- -CHF 1.36
- Beat/Miss
- Beat by +CHF 0.12
- One Year Ago EPS
- -CHF 1.84
CH:UP0 Q2 2024 Revenue Results
- Actual Revenue
- CHF 120.52M
- Expected Revenue
- CHF 100.99M
- Beat/Miss
- Beat by +CHF 19.53M
- YoY Revenue Growth
- +35.75%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/01/2024
- Time
- After Close
- Conference Call
- Thursday, August 1, 2024
CH:UP0 Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
CH:UP0 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:UP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | ―- | -1.06 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.90- | -1.48 | ― | |
| Aug 04, 2026 | 2026 (Q2) | -1.00-0.74 | -0.96 | 23.08% (+0.22) | |
| May 05, 2026 | 2026 (Q1) | -1.22-1.51 | -1.29 | -17.20% (-0.22) | |
| Feb 12, 2026 | 2025 (Q4) | -0.90-1.06 | -1.14 | 7.19% (+0.08) | |
| Nov 04, 2025 | 2025 (Q3) | -1.01-1.48 | -1.15 | -29.29% (-0.34) | |
| Aug 05, 2025 | 2025 (Q2) | -1.06-0.96 | -1.25 | 23.03% (+0.29) | |
| May 06, 2025 | 2025 (Q1) | -1.31-1.29 | -1.66 | 22.66% (+0.38) | |
| Feb 13, 2025 | 2024 (Q4) | -1.07-1.14 | -1.25 | 8.55% (+0.11) | |
| Nov 05, 2024 | 2024 (Q3) | -1.22-1.15 | -1.83 | 37.22% (+0.68) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
